Cardiology

Anti-cholesterol drug Praluent cuts death risk

The anti-cholesterol drug Praluent (alirocumab), made by France's Sanofi Pharmaceuticals, is linked to a 15 percent lower risk of major cardiovascular events like heart attack and stroke, a study said Saturday.

Diabetes

Liraglutide increases heart rate in T2DM with stable CAD

(HealthDay)—Liraglutide increases heart rate (HR) and reduces heart rate variability (HRV) in overweight patients with newly diagnosed type 2 diabetes (T2D) and stable coronary artery disease (CAD), according to a study ...

Health

Try a cholesterol-lowering diet for heart health

With those New Year's resolutions six weeks behind us, some people may have reverted to less healthy ways of eating. Heart Month is a great time to remind yourself why a healthy diet is important for more than just your waistline.

page 19 from 40